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Abstract  
Introduction: Gynaecomastia  (GM)  is  benign  unilateral  or  bilateral  proliferation  of  the
glandular tissue of the breast in males. Its development during adolescence is usually considered
a physiological phenomenon and is expected to resolve within months. Sometimes, however, it is
due to pathological conditions or diseases, and it is not uncommon for these not to be recognized
promptly.  The  present  study aims  to  investigate  the  causes  of  prepubertal  and  pathological
pubertal  GM,  its  association  with  obesity,  the  age  of  appearance,  and  whether  GM  has  a
psychological impact on boys and adolescents admitted to the endocrine department.
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Material and methods: A total of 157 boys and adolescents with GM were included in a cross-
sectional  retrospective study in  a  single  tertiary centre  for  endocrine diseases.  Patients  were
evaluated by anthropometric measurements, serum hormonal levels, and a questionnaire. 
Results: In the period 2009-2018 a total of 157 boys and adolescents were diagnosed with GM
(76.43% obese, 3.18% — overweight). Twelve (7.64 %, mean age of GM development 7.53
years)  were  prepubertal,  5.09%  with  primary  or  secondary  testicular  damage,  5.73%  with
hypogonadotropic hypogonadism, 11.48% with elevated prolactin level, and 110 boys (70.06%)
with physiological pubertal GM. A statistically significant difference was found between the age
of development of physiological GM — 11.85 years (9.35–16.92) and hypergonadotropic —
13.57 years (10-16.25) (p=0.006) and hypogonadotropic — 12.77 years (10.50–14.0) (p = 0.028)
hypogonadism.  Onset  of  pubertal  GM  in  normal-weight  boys  was  13.13  years,  and  in
obese/overweight it was 11.69 years (p < 0.001). Eighty-four patients (53.5%) expressed having
a psychological burden of GM, 12.1% consulted because of its development, in 8.2% it led to
cessation of sports, and 2.5 % changed their clothes.
Conclusions: Prepubertal and pubertal GM has a high association with obesity. Excess adipose
tissue has an impact on the age of development in both groups. Nearly a quarter of pubertal cases
are due to pathological conditions, and those are often diagnosed more than 18 months after the
appearance of breasts. Hence, although a greater number of pubertal GMs are physiological, it
may  be  reasonable  for  adolescents  to  be  evaluated  within  the  first  6  months  of  breast
development so as not to delay the diagnosis of pathologic cases. Additionally, we found that
GM has a complex influence on the psychological state of boys and adolescents.
Key words: prepubertal gynaecomastia, adolescent gynaecomastia, pathological gynaecomastia,
psychological influence of gynaecomastia
Introduction
Gynaecomastia (GM) is a unilateral or bilateral benign proliferation of the glandular tissue of the
breast in males [1]. During 3 periods of an individual’s life GM is considered a physiological
phenomenon — in the neonatal period, during adolescence, and in senile men. GM itself is not a
disease but rather a condition or symptom of an underlying disease that has led to an altered
balance, at the level of breast tissue, between the level and effect of oestrogens and androgens
due to an absolute increase in oestrogen levels, absolute or relative decrease in androgen levels,
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altered bioavailability, disorders of androgen receptors, or hypersensitivity of the glandular tissue
[2, 3, 4]. Overweight and obesity among children and adolescents play an important role in the
development of GM [5, 6]. The causes of pathological GM and its incidence in adult men are
widely known. However, for children and adolescents there are almost no accurate data on the
prevalence of different causes of pathological GM. The aim of the study is to investigate the
causes of prepubertal  and pathological pubertal  GM, and its  association with obesity among
patients admitted to endocrinology clinic. In addition, analysis of its psychological impact was
performed. 
Material and methods
The medical records of boys and adolescents referred to the tertiary department of endocrinology
because of GM or diagnosed with GM during clinical evaluation between 2009 and 2018 were
selected (n = 157) for inclusion in the presented retrospective cross-sectional study. GM was
assessed by means of palpation, and in cases suspicious for pseudo gynaecomastia ultrasound
was  used.  Data  about  age  of  development  of  GM,  anthropometric  (height,  weight)
characteristics,  degree  of  puberty  according  to  Tanner  stages,  as  well  as  hormonal  values
[testosterone (T), luteinizing hormone (LH), follicle-stimulating hormone (FSH), oestradiol (E2),
thyroid-stimulating  hormone  (TSH),  and  prolactin  (Prl)]  were  collected  retrospectively. To
evaluate the psychological impact of GM a questionnaire was used. The hormonal parameters
were measured by means of a chemiluminescent immunoassay (Siemens, Immulite 2000, USA).
Descriptive statistics and frequency analysis were used where appropriate. Comparisons between
groups were made through independent  samples t-test.  p values of  ≤ 0.05 were accepted as
statistically significant. Data were analysed by SPSS (Statistical Package for Social Sciences)
version 13.0.
Results
For  the  aforementioned  period,  from a  total  of  2039  boys  and  adolescents  referred  to  the
Department of Endocrinology, 157 (7.7%) were diagnosed with GM. From them 76.43% were
diagnosed also with obesity,  3.18% were overweight (n = 125), and 20.39 % (n = 32) were
normal weight. Twelve (7.64 %) were below the age of 9 years without pubertal development
and hence were considered as prepubertal. Of the studies performed, the most common cause
was elevated E2 (n = 6), five patient were obese. From the group with elevated E2 one boy had
also elevated prolactin due to therapy with risperidone and sodium valproate, and in another boy
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advanced  bone  maturation  (by 2.5  years)  was  registered.  In  3  more  boys,  with  obesity  but
without increased E2, advanced bone age was registered (12–13 years).
Primary or secondary testicular damage and development of hypergonadotropic hypogonadism
were diagnosed in 8 (5.09%) of the boys. This group included 4 boys with Klinefelter syndrome
(46,  XXY),  one  with a  disorder  of  sexual  differentiation  (karyotype  with  two lines  46,  XX
(25)/47,  XXY (5),  one boy with testicular regression syndrome,  one with acquired testicular
damage  due  to  acute  lymphoblastic  leukaemia,  and  one  patient  had  congenital  unilateral
cryptorchidism with his only testicle surgically removed at 4 years of age.
The third group comprised those with hypogonadotropic hypogonadism — a total  of 9 boys
(5.73%). In this group 2 boys (1.27%) were diagnosed with Kallmann syndrome, and one boy
with a normal sense of smell. Another 5 boys (3,18%) were with constitutional delay in growth
and pubertal development (CDGPD) and low T with elevated E2 in 4 of them. One boy was
diagnosed with hypopituitarism.
Elevated Prl levels were found in 20 boys (1 boy in the prepubertal group and 1 with CDGPD,
and increased E2 and Prl). In this group, 2 more boys (1.28%) were treated with drugs leading to
hyperprolactinaemia (paliperidone, quetiapine, haloperidol). In one boy, elevated prolactin was
found along with elevated TSH due to undiagnosed Hashimoto's thyroiditis. In 3 boys (1.91%)
hyperprolactinaemia led to decreased levels of gonadotropic hormones and delayed puberty. In
the remaining 14 boys, prolactin was elevated at varying degrees but without abnormalities in
gonadotropic hormones or adenohypophyseal hyperplasia (in 6 of them combined with increased
E2).
In 110 boys (70.06%), no other cause of GM was identified, and so they were considered as
physiologically  pubertal.  No  boys  with  GM due  to  tumours,  hyperthyroidism,  chronic  liver
failure, or chronic kidney disease were identified (Tab. 1). 
A statistically  significant  difference  was  found  between  the  mean  age  of  development  of
physiologic pubertal GM and those due to hypergonadotropic (p = 0.006) and hypogonadotropic
(p = 0.028) hypogonadism. The onset of pubertal GM in boys with a normal weight was found at
13.13 years, and in boys with overweight and obesity it was 11.69 years. (p < 0.001). 
Breast  development  is  a  sign  typical  for  females,  and  when GM occurs  in  adolescents  this
happens at an age associated with the development of identity and establishment of self-esteem.
The appearance of breast tissue may lead to anxiety, a sense of difference from one’s peers, as
well as limiting social contact and participation in sport, especially group sports. That is why
patients were asked several questions. Eighty-four patients (53.5%) confessed a psychological
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burden of GM (feeling of shame, embarrassment, reduced well-being, anxiety), 12.1% consulted
because of its development,  in 8.2% GM led to cessation of sports, and 2.5% changed their
clothes.
Discussion
GM among  hospitalized  boys  and adolescents  is  found in  7.7%.  This  value  is  close  to  the
prevalence of 4% of 10–19-year-old Bulgarian boys found by Kumanov et al. [7] but it is 3-times
lower than the incidence of 23% found among Danish boys  [8, 9]. So, it is possible that only a
small number of patients with GM are examined and evaluated, and this may be a reason for
underestimation  of  the  condition,  omission  of  pathologic  GM  and  delay  in  diagnosis.   In
accordance  with this  is  also the fact  that  even in  prepubertal  boys,  GM, which  is  always  a
pathological  condition  that  should  be  evaluated,  the  average  time  before  first  endocrine
evaluation is 18 months (between 0.12 and 5.33 years) (Tab. 1). The sample also shows the high-
grade association of GM and obesity, and illustrates the importance of excess adipose tissue on
the pathogenesis and age of development of prepubertal and pubertal GM. This confirms the
increased incidence of GM in obese individuals found in other studies [10]. In our group, the
percentage of association is even higher, possibly because it was conducted in the last decade.
The current analysis focuses on the pathological cases of GM and finds that nearly 1/3 of them
are due to some hormonal disturbance or disease, and that GM evaluation was the reason for
diagnosis. Therefore, it may be reasonable to recommend a structured and early evaluation of
boys and adolescents with breast development. We suppose this percentage is to some extent due
to the fact that this study was in a tertiary paediatric endocrine unit. Around 25% of children with
GM do not convey importance to breast development, but the majority of patients admit that it
creates a psychological burden, and some gave more than one answer, so the influence of breast
development on the psycho-emotional state is complex. A similar study was conducted by a team
from Turkey [5]. The results obtained in our study show a higher percentage of boys in whom
GM led to emotional discomfort.
We are aware of the limitations that a monocentric retrospective study carries. As a single centre,
the number of patients was limited. This may lead to underestimation of the actual size of the
affected population and omission of rare conditions.  
Conclusions
In conclusion, in our study nearly a quarter of pubertal cases are due to pathological conditions,
which are often diagnosed more than 18 months after the appearance of breasts. Hence, although
5
a greater number of pubertal GMs are physiological, it may be reasonable for adolescents to be
evaluated within the first 6 months of breast development so as not to omit pathological causes
and  delay  the  diagnosis.  Additionally,  we  found  that  GM  has  a  complex  influence  on  the
psychological  state  of  boys  and  adolescents.  Perhaps  early  establishment  of  the  patient’s
condition  may  have  a  positive  impact  on  his  psychological  state,  behaviour,  and  habits,






Datasets are available from the corresponding author on reasonable request after permission from
the local authorities.
References
1. Deepinder  F,  Braunstein  GD.  Gynecomastia:  incidence,  causes  and  treatment.  Expert  Rev
Endocrinol  Metab.  2011;  6(5):  723–730,  doi: 10.1586/eem.11.57,  indexed  in
Pubmed: 30780874.
2. Carlson HE. Approach to the patient with gynecomastia. J Clin Endocrinol Metab. 2011; 96(1):
15–21, doi: 10.1210/jcem.96.9.zeg15a, indexed in Pubmed: 21209041.
3. Rahmani S, Turton P, Shaaban A, et al. Overview of gynecomastia in the modern era and the
Leeds  Gynaecomastia  Investigation  algorithm.  Breast  J.  2011;  17(3):  246–255,
doi: 10.1111/j.1524-4741.2011.01080.x, indexed in Pubmed: 21477170.
4. Bhasin  S.  Testicular  Disorders.  In:  Melmed HM,  Polonsky S,  Larsen KS,  Kronenberg PR.  ed.
Williams Textbook of Endocrinology . Saunders Elsevier, Philadelhia 2008: 669–74.
5. Kilic M, Kanbur N, Derman O, et al. The relationship between pubertal gynecomastia, prostate
specific antigen, free androgen index, SHBG and sex steroids. J Pediatr Endocrinol Metab. 2011;
24(1-2): 61–67, doi: 10.1515/jpem.2011.112, indexed in Pubmed: 21528817.
6. Rivera NF, Eisenstein E, Cardoso CB. [The relation between pubertal gynecomastia and body
mass index in a sample of adolescents attended at the Outpatient Health Unit of a University
6
Hospital].  Arq  Bras  Endocrinol  Metabol.  2009;  53(4):  435–439,  doi: 10.1590/s0004-
27302009000400008, indexed in Pubmed: 19649381.
7. Kumanov  P,  Deepinder  F,  Robeva  R,  et  al.  Relationship  of  adolescent  gynecomastia  with
varicocele  and  somatometric  parameters:  a  cross-sectional  study  in  6200  healthy  boys.  J
Adolesc  Health.  2007;  41(2):  126–131,  doi: 10.1016/j.jadohealth.2007.03.010,  indexed  in
Pubmed: 17659215.
8. Mieritz MG, Sorensen K, Aksglaede L, et al. Elevated serum IGF-I, but unaltered sex steroid
levels, in healthy boys with pubertal gynaecomastia. Clin Endocrinol (Oxf). 2014; 80(5): 691–
698, doi: 10.1111/cen.12323, indexed in Pubmed: 24033660.
9. Mieritz MG, Rakêt LL, Hagen CP, et al. A Longitudinal Study of Growth, Sex Steroids, and IGF-1
in Boys With Physiological Gynecomastia. J Clin Endocrinol Metab. 2015; 100(10): 3752–3759,
doi: 10.1210/jc.2015-2836, indexed in Pubmed: 26287961.
10. Al Alwan I, Al Azkawi H, Badri M, et al. Hormonal, anthropometric and lipid factors associated
with  idiopathic  pubertal  gynecomastia.  Ann  Saudi  Med.  2013;  33(6):  579–583,
doi: 10.5144/0256-4947.2013.579, indexed in Pubmed: 24413862.
Table 1.  Causes and age of development of gynaecomastia in different patients and hormonal
characteristics in the investigated group. Data are presented as median (n), min–max. All groups
include boys and adolescents at different stages of pubertal development. Hormonal values of
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